Vincent-Falquet JC - Search Results

1

Experience with the Vero cell line.

Montagnon BJ, Vincent-Falquet JC. Montagnon BJ, et al. Among authors: vincent falquet jc. Dev Biol Stand. 1998;93:119-23. Dev Biol Stand. 1998. PMID: 9737386 Review.

2

Experience with preexposure rabies vaccination.

Roumiantzeff M, Ajjan N, Vincent-Falquet JC. Roumiantzeff M, et al. Among authors: vincent falquet jc. Rev Infect Dis. 1988 Nov-Dec;10 Suppl 4:S751-7. doi: 10.1093/clinids/10.supplement_4.s751. Rev Infect Dis. 1988. PMID: 3060961 Review.

3

Experience with vero cells at Pasteur Mérieux Connaught.

Montagnon BJ, Vincent-Falquet JC, Saluzzo JF. Montagnon BJ, et al. Among authors: vincent falquet jc. Dev Biol Stand. 1999;98:137-40; discussion 167. Dev Biol Stand. 1999. PMID: 10494966

4

Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.

Montagnon B, Vincent-Falquet JC, Fanget B. Montagnon B, et al. Dev Biol Stand. 1983;55:37-42. Dev Biol Stand. 1983. PMID: 6677539

5

Qualification of working cell banks for the Vero cell line to produce licensed human vaccines.

Vincent-Falquet JC, Peyron L, Souvras M, Moulin JC, Tektoff J, Patet J. Vincent-Falquet JC, et al. Dev Biol Stand. 1989;70:153-6. Dev Biol Stand. 1989. PMID: 2759347

6

Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier.

Montagnon BJ, Fanget B, Vincent-Falquet JC. Montagnon BJ, et al. Among authors: vincent falquet jc. Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S341-4. doi: 10.1093/clinids/6.supplement_2.s341. Rev Infect Dis. 1984. PMID: 6740071

7

Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.

Cadoz M, Montagnon B, Yvonnet B, Xueref C, Vincent-Falquet JC, Bandet R, Gibelin N. Cadoz M, et al. Among authors: vincent falquet jc. Dev Biol Stand. 1986;65:153-8. Dev Biol Stand. 1986. PMID: 2881819 Clinical Trial.

8

Influenza vaccination in the elderly: improved antibody response with Imuthiol (Na diethyldithiocarbamate) adjuvant therapy.

Lesourd BM, Vincent-Falquet JC, Deslandes D, Musset M, Moulias R. Lesourd BM, et al. Among authors: vincent falquet jc. Int J Immunopharmacol. 1988;10(2):135-43. doi: 10.1016/0192-0561(88)90088-4. Int J Immunopharmacol. 1988. PMID: 2836324 Clinical Trial.

9

An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis.

Warrell MJ, Warrell DA, Suntharasamai P, Viravan C, Sinhaseni A, Udomsakdi D, Phanfung R, Xueref C, Vincent-Falquet JC, Nicholson KG, Bunnag D, Harinasuta T. Warrell MJ, et al. Lancet. 1983 Aug 6;2(8345):301-4. doi: 10.1016/s0140-6736(83)90288-x. Lancet. 1983. PMID: 6135830 Clinical Trial.

10

[The passive hemagglutination test in the evaluation of antitetanus immunity].

Rey M, Fontanges R, Robert D, Tayot JL, Relyveld EH, Vincent-Falquet JC, Durand B. Rey M, et al. Dev Biol Stand. 1978;41:55-63. Dev Biol Stand. 1978. PMID: 753670 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results